Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort
Published Online: 2014-05-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alla Bozhok•Ana Lluch•Angela Moliterni•Belen Ojeda•Domenico Magazzù•Dominik Heinzmann•Eva Ciruelos•Federico Vazquez•Jose Baselga•Jutta Steinseifer•Luca Gianni•Mauro Mansutti•Miguel Angel Climent•Mikhail J Byakhov•Mikhail Lichinitser•Milvia Zambetti•Pinuccia Valagussa•Sergei Tjulandin•Vladimir Semiglazov•Wolfgang Eiermann